EUVIMEDEUVIMED entdecken
Crossref

Novel Likely Pathogenic Variant in the A3 Domain of von Willebrand Factor Leading to a Collagen-Binding Defect

Salome Fels, Doris Boeckelmann, Hannah Glonnegger, Martin Büchsel, Barbara Zieger

Hämostaseologie · 01.04.2023 · 43 (02) · 122-125

DOI: 10.1055/a-1701-2181 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hämostaseologie, erschienen am 01.04.2023. Verfasst von Salome Fels und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Faculty of Medicine, Medical Center - University of …. Hauptthemen laut MEDLINE: von Willebrand Factor, von Willebrand Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 3 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Von Willebrand disease (VWD) is the most prevalent congenital bleeding disorder. Diagnosis and classification of VWD is complex due to its heterogeneity regarding clinical manifestations and molecular genetic analysis. Genetic investigations became an inherent part of diagnosis and help distinguish different types/subtypes of VWD. Although many variants have been listed being causative for VWD, the genetic etiology remains undefined in a lot of patients. We report about two siblings with severely reduced values for von Willebrand factor collagen-binding activity (VWF:CB). Genetic analysis using panel sequencing identified a heterozygous non-synonymous single nucleotide variant in exon 30. At the protein level, the alteration (p.Ser1731Leu) is located in the A3 collagen-binding domain. The amino acid position is already known to be important for collagen binding because p.Ser1731Thr has been reported to affect the VWF:CB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

von Willebrand Factorvon Willebrand DiseasesHumansHeterozygoteExonsCollagen

Substanzen

von Willebrand FactorCollagen

Autor:innen und Institutionen

  • Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Faculty of Medicine, Medical Center - University of Freiburg, Germany.
  • Institute of Clinical Chemistry and Laboratory Medicine, Faculty of Medicine, Medical Center - University of Freiburg, Germany.

Zitieren

APA

Fels, S., Boeckelmann, D., Glonnegger, H., Büchsel, M., & Zieger, B. (2023). Novel Likely Pathogenic Variant in the A3 Domain of von Willebrand Factor Leading to a Collagen-Binding Defect. Hämostaseologie, 43(02), 122-125. https://doi.org/10.1055/a-1701-2181

Vancouver

Fels S, Boeckelmann D, Glonnegger H, Büchsel M, Zieger B. Novel Likely Pathogenic Variant in the A3 Domain of von Willebrand Factor Leading to a Collagen-Binding Defect. Hämostaseologie. 2023;43(02):122-125. doi:10.1055/a-1701-2181

BibTeX
@article{Fels2023,
  author = {Fels, Salome and Boeckelmann, Doris and Glonnegger, Hannah and Büchsel, Martin and Zieger, Barbara},
  title = {Novel Likely Pathogenic Variant in the A3 Domain of von Willebrand Factor Leading to a Collagen-Binding Defect},
  journal = {Hämostaseologie},
  year = {2023},
  volume = {43},
  number = {02},
  pages = {122--125},
  doi = {10.1055/a-1701-2181}
}
Kostenlos starten →